Literature DB >> 24585727

Arrhythmogenic right ventricular dysplasia/cardiomyopathy and cardiac sarcoidosis: distinguishing features when the diagnosis is unclear.

Binu Philips1, Srinivasa Madhavan, Cynthia A James, Anneline S J M te Riele, Brittney Murray, Crystal Tichnell, Aditya Bhonsale, Saman Nazarian, Daniel P Judge, Hugh Calkins, Harikrishna Tandri, Alan Cheng.   

Abstract

BACKGROUND: Cardiac sarcoidosis (CS) may show overlap in the clinical presentation with arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C). We sought to investigate patients with CS who were misdiagnosed with ARVD/C and identify clinical features to distinguish these 2 groups. METHODS AND
RESULTS: Among patients enrolled in the Johns Hopkins ARVD/C registry, 15 patients with definite 2010 diagnostic criteria for ARVD/C were subsequently diagnosed with CS. Forty-two pathogenic desmosomal mutation carriers with definite ARVD/C based on the 2010 diagnostic criteria served as a control group. Patients with CS were older at the age of symptom onset, more likely to have comorbidities, and develop heart failure symptoms over time (P<0.05). Electrocardiographically, PR interval prolongation and high-grade atrioventricular block were exclusively associated with CS (P<0.05). HV interval prolongation and increased number of ventricular tachycardias induced were also associated with CS (P<0.05). Radiographically, significant left ventricular dysfunction, myocardial delayed enhancement of the septum, and mediastinal lymphadenopathy were more often see in those with CS (P<0.05).
CONCLUSIONS: The 2010 diagnostic criteria for ARVD/C have limited discrimination in distinguishing between ARVD/C and CS. Despite the overlay in clinical presentation, older age of symptom onset, presence of cardiovascular comorbidities, nonfamilial pattern of disease, PR interval prolongation, high-grade atrioventricular block, significant left ventricular dysfunction, myocardial delayed enhancement of the septum, and mediastinal lymphadenopathy should raise the suspicion for CS.

Entities:  

Keywords:  arrhythmogenic right ventricular dysplasia; diagnosis; sarcoidosis

Mesh:

Year:  2014        PMID: 24585727     DOI: 10.1161/CIRCEP.113.000932

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  31 in total

1.  Incidence of abnormal positron emission tomography in patients with unexplained cardiomyopathy and ventricular arrhythmias: The potential role of occult inflammation in arrhythmogenesis.

Authors:  Roderick Tung; Brenton Bauer; Heinrich Schelbert; Joseph P Lynch; Martin Auerbach; Pawan Gupta; Christiaan Schiepers; Samantha Chan; Julie Ferris; Martin Barrio; Olujimi Ajijola; Jason Bradfield; Kalyanam Shivkumar
Journal:  Heart Rhythm       Date:  2015-08-10       Impact factor: 6.343

2.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Saenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  J Interv Card Electrophysiol       Date:  2020-10       Impact factor: 1.900

3.  Catheter ablation of ventricular tachycardia associated with cardiac sarcoidosis: Targeting a low-voltage area with strict voltage criteria.

Authors:  Satoshi Higuchi; Koichiro Ejima; Tetsuyuki Manaka; Morio Shoda; Nobuhisa Hagiwara
Journal:  J Cardiol Cases       Date:  2014-07-28

4.  Role of PET/CT in multimodality imaging in differentiating cardiac sarcoidosis from arrhythmogenic right ventricular dysplasia.

Authors:  Cheng Yee Goh; Adam Gay; Michael S Hofman; Chiew Wong; James Westcott; Nathan Better
Journal:  J Nucl Cardiol       Date:  2018-07-26       Impact factor: 5.952

Review 5.  Molecular mechanisms in the pathogenesis of arrhythmogenic cardiomyopathy.

Authors:  Jeffrey E Saffitz
Journal:  Cardiovasc Pathol       Date:  2017-02-27       Impact factor: 2.185

6.  Sports in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy and desmosomal mutations.

Authors:  A C Sawant; H Calkins
Journal:  Herz       Date:  2015-05       Impact factor: 1.443

7.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Sáenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  Europace       Date:  2019-08-01       Impact factor: 5.214

Review 8.  Updates on the Role of Imaging in Cardiac Sarcoidosis.

Authors:  Yan Yatsynovich; Damian Valencia; Mikhail Petrov; Juan David Linares; Mufti M Rahman; Nathaniel Dittoe
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-08-07

9.  Arrhythmogenic left ventricular cardiomyopathy.

Authors:  Domenico Corrado; Cristina Basso
Journal:  Heart       Date:  2021-07-13       Impact factor: 5.994

Review 10.  Challenges in Cardiac and Pulmonary Sarcoidosis: JACC State-of-the-Art Review.

Authors:  Maria Giovanna Trivieri; Paolo Spagnolo; David Birnie; Peter Liu; Wonder Drake; Jason C Kovacic; Robert Baughman; Zahi A Fayad; Marc A Judson
Journal:  J Am Coll Cardiol       Date:  2020-10-20       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.